PhRMA Seeks To Enjoin District Of Columbia Drug Pricing Law
This article was originally published in The Pink Sheet Daily
PhRMA fails in its attempt to obtain a temporary restraining order barring the district from implementing price control measures.
You may also be interested in...
District court judge determines the law violates the Commerce Clause and the Supremacy Clause of the Constitution.
FDA is clarifying that it expects sponsors to provide analysis of efficacy data rather than simply a summary of clinical data as part of the integrated summary of effectiveness in new drug applications